- Nachrichtendetail
-
02.02.2024 12:22:52 - dpa-AFX: *REGENERON PHARMA: EMA ACCEPTS FOR REVIEW MAA FOR LINVOSELTAMAB TO TREAT R/R MULTIPLE MYELOMA
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Regeneron Pharmaceuticals | 881535 | NASDAQ | 992,860 | 21.05.24 21:00:02 | +5,590 | +0,57% | 992,340 | 993,520 | 987,990 | 987,270 |
